GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,770.50
-5.00 (-0.28%)
Sep 11, 2026, 4:54 PM GMT
GSK plc Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 70,944 | 73,201 | 54,944 | 59,112 | 58,381 | 80,458 | |
Market Cap Growth | 18.17% | 33.23% | -7.05% | 1.25% | -27.44% | 20.44% |
Enterprise Value | 85,663 | 87,249 | 67,236 | 72,751 | 72,899 | 108,871 |
Last Close Price | 17.70 | 17.77 | 12.56 | 13.02 | 12.41 | 13.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.02 | 12.81 | 21.34 | 12.00 | 3.90 | 18.35 |
Forward PE | 9.60 | 10.18 | 8.39 | 9.38 | 10.01 | 14.00 |
PS Ratio | 2.14 | 2.24 | 1.75 | 1.95 | 1.99 | 3.26 |
PB Ratio | 4.13 | 4.59 | 4.20 | 4.62 | 5.78 | 3.77 |
P/FCF Ratio | 10.28 | 11.45 | 10.66 | 10.84 | 9.33 | 11.49 |
P/OCF Ratio | 8.52 | 9.46 | 8.38 | 8.73 | 7.89 | 10.12 |
PEG Ratio | 1.75 | 1.35 | 1.21 | 1.37 | 0.88 | 2.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.58 | 2.67 | 2.14 | 2.40 | 2.49 | 4.41 |
EV/EBITDA Ratio | 7.77 | 7.70 | 8.08 | 6.92 | 7.84 | 14.04 |
EV/EBIT Ratio | 8.85 | 9.24 | 10.86 | 8.66 | 9.96 | 19.32 |
EV/FCF Ratio | 12.42 | 13.65 | 13.04 | 13.34 | 11.65 | 15.55 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.07 | 1.12 | 1.30 | 1.41 | 2.08 | 1.13 |
Debt / EBITDA Ratio | 1.66 | 1.54 | 1.99 | 1.68 | 2.22 | 3.12 |
Debt / FCF Ratio | 2.65 | 2.78 | 3.30 | 3.30 | 3.35 | 3.45 |
Net Debt / Equity Ratio | 0.88 | 0.90 | 1.00 | 1.00 | 1.28 | 0.90 |
Net Debt / EBITDA Ratio | 1.40 | 1.27 | 1.57 | 1.21 | 1.39 | 2.48 |
Net Debt / FCF Ratio | 2.20 | 2.25 | 2.53 | 2.34 | 2.07 | 2.74 |
Asset Turnover | 0.55 | 0.54 | 0.53 | 0.51 | 0.42 | 0.31 |
Inventory Turnover | 1.43 | 1.54 | 1.58 | 1.58 | 1.72 | 1.36 |
Quick Ratio | 0.52 | 0.50 | 0.50 | 0.60 | 0.66 | 0.53 |
Current Ratio | 0.82 | 0.82 | 0.78 | 0.89 | 0.91 | 0.79 |
Return on Equity (ROE) | 33.38% | 43.31% | 22.80% | 46.38% | 31.31% | 16.68% |
Return on Assets (ROA) | 10.01% | 9.79% | 6.53% | 8.82% | 6.57% | 4.41% |
Return on Invested Capital (ROIC) | 26.38% | 28.45% | 20.35% | 30.29% | 20.14% | 13.48% |
Return on Capital Employed (ROCE) | 24.10% | 23.80% | 16.40% | 22.10% | 19.60% | 10.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.80% | 7.81% | 4.69% | 8.34% | 25.62% | 5.45% |
FCF Yield | 9.72% | 8.73% | 9.38% | 9.23% | 10.72% | 8.70% |
Dividend Yield | 3.87% | 3.71% | 4.86% | 4.45% | 4.94% | 7.46% |
Payout Ratio | 55.30% | 44.86% | 94.91% | 45.60% | 23.18% | 91.20% |
Buyback Yield / Dilution | 1.36% | 0.60% | -0.75% | -0.66% | -0.79% | -0.55% |
Total Shareholder Return | 5.23% | 4.32% | 4.10% | 3.79% | 4.15% | 6.92% |